Detalhe da pesquisa
1.
Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised study.
Clin Exp Rheumatol
; 40(5): 1025-1033, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34251303
2.
A drug-drug interaction study of a novel, selective urate reabsorption inhibitor dotinurad and the non-steroidal anti-inflammatory drug oxaprozin in healthy adult males.
Clin Exp Nephrol
; 24(Suppl 1): 36-43, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32076889
3.
Dotinurad: a clinical pharmacokinetic study of a novel, selective urate reabsorption inhibitor in subjects with hepatic impairment.
Clin Exp Nephrol
; 24(Suppl 1): 25-35, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31760530
4.
Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate.
Ann Rheum Dis
; 77(4): 488-494, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29259050
5.
Long-term use of dienogest in the treatment of painful symptoms in adenomyosis.
J Obstet Gynaecol Res
; 43(9): 1441-1448, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28737239
6.
Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study.
Intest Res
; 16(2): 255-266, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29743838
7.
Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study.
Fertil Steril
; 108(4): 673-678, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28911934
8.
Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind study.
Intest Res
; 15(3): 358-367, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28670233
9.
Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study.
Intest Res
; 15(3): 368-379, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28670234
10.
A randomized, double-blind, placebo-controlled study of escitalopram in patients with social anxiety disorder in Japan.
Curr Med Res Opin
; 32(4): 749-57, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26808688
11.
Long-term administration of escitalopram in patients with social anxiety disorder in Japan.
Neuropsychiatr Dis Treat
; 12: 1817-25, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27524899
12.
Efficacy of escitalopram in the treatment of social anxiety disorder: A meta-analysis versus placebo.
Eur Neuropsychopharmacol
; 26(6): 1062-9, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26971233
13.
Statistical comparison of random allocation methods in cancer clinical trials.
Control Clin Trials
; 25(6): 572-84, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15588744